165 related articles for article (PubMed ID: 17189429)
1. Reduced levels of ATF-2 predispose mice to mammary tumors.
Maekawa T; Shinagawa T; Sano Y; Sakuma T; Nomura S; Nagasaki K; Miki Y; Saito-Ohara F; Inazawa J; Kohno T; Yokota J; Ishii S
Mol Cell Biol; 2007 Mar; 27(5):1730-44. PubMed ID: 17189429
[TBL] [Abstract][Full Text] [Related]
2. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.
Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S
Oncogene; 2008 Feb; 27(8):1045-54. PubMed ID: 17700520
[TBL] [Abstract][Full Text] [Related]
3. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice.
Zhang M; Shi Y; Magit D; Furth PA; Sager R
Oncogene; 2000 Dec; 19(52):6053-8. PubMed ID: 11146557
[TBL] [Abstract][Full Text] [Related]
4. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence.
Tront JS; Hoffman B; Liebermann DA
Cancer Res; 2006 Sep; 66(17):8448-54. PubMed ID: 16951155
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
6. Investigating maspin in breast cancer progression using mouse models.
Endsley MP; Zhang M
Methods Enzymol; 2011; 499():149-65. PubMed ID: 21683253
[TBL] [Abstract][Full Text] [Related]
7. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
8. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
9. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2.
Kool J; Hamdi M; Cornelissen-Steijger P; van der Eb AJ; Terleth C; van Dam H
Oncogene; 2003 Jul; 22(27):4235-42. PubMed ID: 12833146
[TBL] [Abstract][Full Text] [Related]
10. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
11. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis.
Li Z; Shi HY; Zhang M
Oncogene; 2005 Mar; 24(12):2008-19. PubMed ID: 15688005
[TBL] [Abstract][Full Text] [Related]
12. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
13. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
[TBL] [Abstract][Full Text] [Related]
15. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
[TBL] [Abstract][Full Text] [Related]
16. The role of ATF-2 in oncogenesis.
Vlahopoulos SA; Logotheti S; Mikas D; Giarika A; Gorgoulis V; Zoumpourlis V
Bioessays; 2008 Apr; 30(4):314-27. PubMed ID: 18348191
[TBL] [Abstract][Full Text] [Related]
17. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
18. The role of X-linked genes in breast cancer.
Thakur A; Xu H; Wang Y; Bollig A; Biliran H; Liao JD
Breast Cancer Res Treat; 2005 Sep; 93(2):135-43. PubMed ID: 16187233
[TBL] [Abstract][Full Text] [Related]
19. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
[TBL] [Abstract][Full Text] [Related]
20. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
